Does ANAKINRA Cause Disseminated intravascular coagulation? 18 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Disseminated intravascular coagulation have been filed in association with ANAKINRA (Kineret). This represents 0.2% of all adverse event reports for ANAKINRA.
18
Reports of Disseminated intravascular coagulation with ANAKINRA
0.2%
of all ANAKINRA reports
14
Deaths
15
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From ANAKINRA?
Of the 18 reports, 14 (77.8%) resulted in death, 15 (83.3%) required hospitalization, and 12 (66.7%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANAKINRA. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does ANAKINRA Cause?
Off label use (4,317)
Drug ineffective (3,368)
Pain (1,344)
Condition aggravated (1,339)
Rheumatoid arthritis (1,300)
Drug intolerance (946)
Joint swelling (921)
Injection site pain (879)
Product dose omission issue (864)
Arthralgia (850)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which ANAKINRA Alternatives Have Lower Disseminated intravascular coagulation Risk?
ANAKINRA vs ANAMORELIN
ANAKINRA vs ANASTROZOLE
ANAKINRA vs ANDEXANET ALFA
ANAKINRA vs ANDROGEL
ANAKINRA vs ANETHOLTRITHION